Status:
UNKNOWN
Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain
Lead Sponsor:
Medical University of Silesia
Conditions:
Clostridium Difficile
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study was to analyze whether the use of the LP299v strain reduces the risk of Clostridium difficile infection (CDI) among patients receiving antibiotics and hospitalized in the nephrol...
Detailed Description
Clostridium difficile is currently the most frequently identified pathogen causing antibiotic-associated diarrhoea and the main cause of nosocomial diarrhoea. In regard to observed worldwide increase ...
Eligibility Criteria
Inclusion
- over 18 years old
- organ transplantation or receiving immunosuppressive drugs for any other reasons
- antibiotics therapy
Exclusion
- no consent to participate in the study
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03368105
Start Date
January 1 2018
End Date
July 1 2021
Last Update
December 11 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.